Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has successfully dosed the ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

Panelists discuss how aflibercept 8 mg maintains a safety profile similar to 2 mg and how workflow, systemic risk, and ...

Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

Report analyzes publicly available category information, company-stated product details, and consumer search patterns as ...

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...

Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

A comprehensive industry examination reveals what manufacturer disclosures, clinical study documentation, and delivery system ...

HealthBiome Inc., a pioneering strict anaerobic microbiome company, announced today that it has achieved significant regulatory milestones in both the United States and South Korea for its proprietary ...

The convenience and lower cost of the oral pill may be critical to some patients, which could expand the market, improve ...

RedHill Biopharma shares fell after a sharp rally as investors took profits, following updates on its GI drug aimed at easing ...